» Articles » PMID: 34169411

The Potential Use of Mesenchymal Stem Cells and Their Derived Exosomes for Orthopedic Diseases Treatment

Overview
Publisher Springer
Specialty Cell Biology
Date 2021 Jun 25
PMID 34169411
Citations 47
Authors
Affiliations
Soon will be listed here.
Abstract

Musculoskeletal disorders (MSDs) are conditions that can affect muscles, bones, and joints. These disorders are very painful and severely limit patients' mobility and are more common in the elderly. MSCs are multipotent stem cells isolated from embryonic (such as the umbilical cord) and mature sources (such as adipose tissue and bone marrow). These cells can differentiate into various cells such as osteoblasts, adipocytes, chondrocytes, NP-like cells, Etc. Due to MSC characteristics such as immunomodulatory properties, ability to migrate to the site of injury, recruitment of cells involved in repair, production of growth factors, and large amount production of extracellular vesicles, these cells have been used in many regenerative-related medicine studies. Also, MSCs produce different types of EVs, such as exosomes, to the extracellular environment. Exosomes reflect MSCs' characteristics and do not have cell therapy-associated problems because they are cell-free. These vesicles carry proteins, nucleic acids, and lipids to the host cell and change their function. This review focuses on MSCs and MSCs exosomes' role in repairing dense connective tissues such as tendons, cartilage, invertebrate disc, bone fracture, and osteoporosis treatment.

Citing Articles

Mesenchymal stem cells derived exosomes: a new era in cardiac regeneration.

Rayat Pisheh H, Sani M Stem Cell Res Ther. 2025; 16(1):16.

PMID: 39849585 PMC: 11756228. DOI: 10.1186/s13287-024-04123-2.


Therapeutic Efficacy and Promise of Human Umbilical Cord Mesenchymal Stem Cell-Derived Extracellular Vesicles in Aging and Age-Related Disorders.

Zhang A, Li Q, Chen Z Int J Mol Sci. 2025; 26(1.

PMID: 39796081 PMC: 11719504. DOI: 10.3390/ijms26010225.


Adipose Mesenchymal Stem Cell-Derived Exosomes as Nanocarriers for Treating Musculoskeletal Disorders.

Tang A, Shu Q, Jia S, Lai Z, Tian J Int J Nanomedicine. 2024; 19:13547-13562.

PMID: 39720215 PMC: 11668248. DOI: 10.2147/IJN.S486622.


Mesenchymal stem cell application in pulmonary disease treatment with emphasis on their interaction with lung-resident immune cells.

Hazrati A, Mirarefin S, Malekpour K, Rahimi A, Khosrojerdi A, Rasouli A Front Immunol. 2024; 15:1469696.

PMID: 39582867 PMC: 11581898. DOI: 10.3389/fimmu.2024.1469696.


Revolutionizing medicine: recent developments and future prospects in stem-cell therapy.

Hussen B, Hussen B, Taheri M, Yashooa R, Abdullah G, Abdullah S Int J Surg. 2024; 110(12):8002-8024.

PMID: 39497543 PMC: 11634165. DOI: 10.1097/JS9.0000000000002109.


References
1.
Liu W, Li L, Rong Y, Qian D, Chen J, Zhou Z . Hypoxic mesenchymal stem cell-derived exosomes promote bone fracture healing by the transfer of miR-126. Acta Biomater. 2019; 103:196-212. DOI: 10.1016/j.actbio.2019.12.020. View

2.
Burrello J, Monticone S, Gai C, Gomez Y, Kholia S, Camussi G . Stem Cell-Derived Extracellular Vesicles and Immune-Modulation. Front Cell Dev Biol. 2016; 4:83. PMC: 4992732. DOI: 10.3389/fcell.2016.00083. View

3.
Xiang C, Yang K, Liang Z, Wan Y, Cheng Y, Ma D . Sphingosine-1-phosphate mediates the therapeutic effects of bone marrow mesenchymal stem cell-derived microvesicles on articular cartilage defect. Transl Res. 2018; 193:42-53. DOI: 10.1016/j.trsl.2017.12.003. View

4.
Curtis E, Moon R, Dennison E, Harvey N, Cooper C . Recent advances in the pathogenesis and treatment of osteoporosis. Clin Med (Lond). 2016; 16(4):360-4. PMC: 5011415. DOI: 10.7861/clinmedicine.16-4-360. View

5.
Zhao P, Xiao L, Peng J, Qian Y, Huang C . Exosomes derived from bone marrow mesenchymal stem cells improve osteoporosis through promoting osteoblast proliferation via MAPK pathway. Eur Rev Med Pharmacol Sci. 2018; 22(12):3962-3970. DOI: 10.26355/eurrev_201806_15280. View